(Q28200183)

14 March 2019

19 March 2019

22 March 2019

17 June 2019

19 September 2019

on focus list of Wikimedia project

2 October 2020

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Mortality by cause for eight regions of the world: Global Burden of Disease Study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Systematic reviews in health care: Assessing the quality of controlled clinical trials

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Health and economic outcomes modeling practices: a suggested framework

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Systematic review of the use and value of computer simulation modelling in population health and health care delivery

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Substantial potential for reductions in coronary heart disease mortality in the UK through changes in risk factor levels

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Estimating the population impact of an intervention: a decision-analytic approach

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

The health benefits of prevention: a simulation approach

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

The selection of data sources for use in modelling studies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Cost-effectiveness of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in the secondary prevention of cardiovascular disease: forecasting the incremental benefits of preventing coronary and cerebrovascular events

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Estimating the benefits of modifying risk factors of cardiovascular disease: a comparison of primary vs secondary prevention

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Modelling the effects of increased physical activity on coronary heart disease in England and Wales

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

The benefits of treating hyperlipidemia to prevent coronary heart disease. Estimating changes in life expectancy and morbidity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Choosing the preventive workload in general practice: practical application of the Coronary Prevention Group guidelines and Dundee coronary risk-disk

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Health and economic benefits of increased beta-blocker use following myocardial infarction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1560128

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

2 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-213

The primary health care team: history and contractual farces

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-213

Modeling for health care and other policy decisions: uses, roles, and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-213

Computer-assisted health impact assessment for intersectoral health policy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-213

Predicting the effect of prevention of ischaemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-213

The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-213

The cost-effectiveness of HMG-CoA reductase inhibitors to prevent coronary heart disease. Estimating the benefits of increasing HDL-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-213

Life-years gained from coronary heart disease mortality reduction in Scotland: prevention or treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-213

Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-213

Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-6-213

Estimating Mortality Due to Cigarette Smoking: Two Methods, Same Result

21 January 2018

2 references

https://api.crossref.org/works/10.1186%2F1471-2458-6-213

21 January 2018

12 December 2020

Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics

1 reference

12 December 2020

Expected gains in life expectancy from various coronary heart disease risk factor modifications

1 reference

12 December 2020

Why model coronary heart disease?

1 reference

12 December 2020

Treating hyperlipidemia for the primary prevention of coronary disease. Are higher dosages of lovastatin cost-effective?

1 reference

12 December 2020

Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000

1 reference

12 December 2020

Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model

1 reference

12 December 2020

The development of a simulation model of primary prevention strategies for coronary heart disease

1 reference

12 December 2020

Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993

1 reference

12 December 2020

A model for evaluating the cost-effectiveness of cholesterol-lowering treatment

1 reference

12 December 2020

Reducing the burden of coronary heart disease: health promotion, its effectiveness and cost

1 reference

12 December 2020

The development of a simulation model of the treatment of coronary heart disease

1 reference

12 December 2020

An assessment of models of a health system

1 reference

12 December 2020

Probabilistic analysis of cost-effectiveness models: statistical representation of parameter uncertainty

1 reference

12 December 2020

The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2458-6-213

1 reference

Dimensions Publication ID

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/1471-2458-6-213

1 reference

1 reference

PubMed publication ID

16919155

1 reference